Navigation Links
Federal Judge Rejects Tobacco Companies' Effort to Block Key Provisions of New Tobacco Regulation Law

Statement of Campaign for Tobacco-Free Kids, American Cancer Society, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association and American Legacy Foundation

WASHINGTON, Nov. 5 /PRNewswire-USNewswire/ -- In a clear victory for public health, a federal judge in Kentucky today rejected a motion by tobacco companies to block key provisions of the new law giving the U.S. Food and Drug Administration (FDA) the power to regulate tobacco products. Specifically, today's decision strongly supports the government's authority to prevent the industry from making health claims about its products without FDA approval.


We applaud the federal court's decision to quickly and decisively reject the latest attempt by Big Tobacco to frustrate the intent of the new FDA law and allow the agency to get on with its role in putting an end to deceptive and dangerous tobacco marketing.

Eleven public health and consumer advocacy groups joined in the legal effort to thwart the industry's challenge to the law based on the claim that its First Amendment rights were violated. U.S. District Court Judge Joseph H. McKinley denied a request from R.J. Reynolds and other tobacco companies to keep the FDA from implementing the law, saying they have "little likelihood" in proving that their free speech rights have been harmed. Judge McKinley forcefully backed the government's interest in protecting consumers from misleading claims about tobacco products with supposedly reduced health risks.

The judge agreed with the key argument that "given the significant health risks associated with the use of tobacco products and the history of marketing 'low tar' and 'light' cigarettes," the government "has a substantial interest in protecting consumers from misleading tobacco industry claims about allegedly reduced risk tobacco products."

The court's ruling supports the portion of the FDA law that requires tobacco companies to submit for the agency's review any claims of reduced risk. The FDA is empowered to determine if the claim is scientifically justified and benefits public health. McKinley cited a pivotal ruling in the Department of Justice's racketeering lawsuit against the tobacco companies, noting that tobacco companies have a "history of advancing their bottom line by misleading consumers about the health risks associated with their products."

The groups who joined the government in supporting the FDA law are: The Campaign for Tobacco-Free Kids, American Cancer Society, American Cancer Society Cancer Action Network, American Heart Association, American Legacy Foundation, American Lung Association, American Medical Association, American Public Health Association, Kentucky Medical Association, Oncology Nursing Society and Public Citizen.

Tobacco use is the leading preventable cause of death in the United States, killing more than 400,000 people and costing $96 billion in health care costs annually.

SOURCE Campaign for Tobacco-Free Kids

SOURCE Campaign for Tobacco-Free Kids
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Federal stimulus funds support studies geared to improving HIV care and prevention
2. School Violence Drops With Federal Program
3. MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale
4. Cardiac Patients Across Rural America Risk Losing Access to Nearby Care as Federal Agency Considers Cuts this Week
5. Bolton School of Nursing at CWRU receives $3.7 million in federal stimulus funding
6. Judge Halts IHSS Home Care Cuts; Says They Likely Violate Federal Law
7. IPRO Wins Federal Contract to Support Hospice Oversight
8. Homecare Recipients and Providers to Rally against Cuts in IHSS Program; Hearing on Lawsuit in Oakland Federal Court Monday
9. Department of Public Welfare Earns Federal Recognition for Programs and Services for Children
10. NeuroAIDS is Target of Federal Grant to Childrens Hospital
11. Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia
Post Your Comments:
(Date:12/1/2015)... ... 01, 2015 , ... The workstation boundaries for imaging specialists ... Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated medical image display, debuting ... December 4, 2015. , MED-TAB is expected to change teleradiology because for ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... keeping their independence is everything. That is why Hollister Incorporated has launched the ... to offer this next product in the VaPro touch free catheter portfolio,” said ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, VA., ... awarded a fixed price per sprint agile development contract to support the National ... over five years, provides software engineering, infrastructure, as well as operations and sustainment ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 - ... to head to Las Vegas for CES 2016, the world’s largest Consumer Electronic Show, ... Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture capitalist ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Arash ... Modern Man for 2015. , Angeleno Magazine is a division of Modern ... in 1994, Modern Luxury includes more than 50 magazine titles across 15 major ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VIEJO, Calif. , Dec. 1, 2015 /PRNewswire/ ... the prevalence of symptoms for pseudobulbar affect (PBA), ... outbursts of laughing and/or crying resulting from certain ... use of antipsychotic medications in nursing home residents, ... Geriatric Psychiatry. The study showed that almost one ...
(Date:12/1/2015)... 1, 2015 ... of the  "2016 Shigella Testing Market: ... Competitive Strategies, Emerging Opportunities--US, Europe (France, ... to their offering. --> ... of the  "2016 Shigella Testing Market: ...
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 ... through its wholly-owned UK subsidiary Proximagen Ltd., today announced ... novel, oral small molecule inhibitor of Vascular Adhesion Protein ... in the treatment of inflammatory disease. The VAP-1 inhibitor ... --> --> Under the terms ...
Breaking Medicine Technology: